perioperative chemotherapy
Showing 1 - 25 of >10,000
Colorectal Tumors Trial in Gent (perioperative chemo plus bevacizumab, cytoreductive surgery, Intraperitoneal Oxaliplatin)
Active, not recruiting
- Colorectal Neoplasms
- perioperative chemotherapy plus bevacizumab
- +2 more
-
Gent, BelgiumGhent University Hospital
Dec 12, 2022
Gastric Cancer Trial in Mykolaiv (Docetaxel, Oxaliplatin, Leucovorin)
Active, not recruiting
- Gastric Cancer
- Docetaxel
- +4 more
-
Mykolaiv, UkraineUkrainian Society of Clinical Oncology
Apr 11, 2022
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Jul 25, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer Trial in China
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Feb 7, 2023
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 30, 2023
Gastroesophageal Junction Adenocarcinoma, Stomach Tumors Trial in Barcelona (Avelumab addition to perioperative chemo in GC and
Recruiting
- Gastroesophageal Junction Adenocarcinoma
- Stomach Neoplasms
- Avelumab addition to perioperative chemotherapy in GC and GEJC
-
Barcelona, SpainVall d'Hebron Institute of Oncology
Oct 11, 2022
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- S1
- +3 more
-
Hangzhou, Zhejiang, China
- +4 more
May 23, 2023
Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
-
Shanghai, Shanghai, ChinaShanghai chest hospital
Sep 24, 2023
Gastric Cancer Trial in Xi'an (Penpulimab combined with Anlotinib Hydrochloride Capsules and chemo;Cadonilimab combined with
Not yet recruiting
- Gastric Cancer
- Penpulimab combined with Anlotinib Hydrochloride Capsules and chemotherapy;Cadonilimab combined with Anlotinib Hydrochloride Capsules and chemotherapy
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Air Force Military Medical Univ
Mar 23, 2023
Gastric Cancer Trial in Krakow (FLOT4 + HIPEC + Surgery, FLOT4 + Surgery)
Recruiting
- Gastric Cancer
- FLOT + HIPEC + Surgery
- FLOT + Surgery
-
Krakow, Lesser Poland Voivodship, PolandDepartment of General, Oncological, Gastroenterological Surgery
Nov 9, 2022
MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)
Not yet recruiting
- MSI-H Colorectal Cancer
- +3 more
- (no location specified)
Apr 23, 2023
Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency Trial in China
Not yet recruiting
- Adenocarcinoma of the Stomach
- +2 more
- Toripalimab
- +2 more
-
Hangzhou, Zhejiang, China
- +7 more
Feb 7, 2023
Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Oligometastatic Disease
- FOLFIRINOX chemotherapy
-
Baltimore, MarylandJohns Hopkins Hospital
Nov 2, 2023
Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)
Recruiting
- Gastric Cancer
- +3 more
- leucovorin, oxaliplatin, docetaxel, S-1
-
Kaohsiung, Taiwan
- +3 more
May 24, 2022
COMPARATIVE EFFECTS OF PERIOPERATIVE AND ADJUVANT CHEMOTHERAPY
Completed
- Gastric Cancer, Outcomes, Pakistan, Adjuvant Chemotherapy, Perioperative Chemotherapy
- (no location specified)
Aug 3, 2021
Esophageal Adenocarcinoma (UICC TNM7), Adenocarcinoma of the Esophagogastric Junction Trial in Germany (5-Fluorouracil,
Active, not recruiting
- Esophageal Adenocarcinoma (UICC TNM7)
- Adenocarcinoma of the Esophagogastric Junction
- 5-Fluorouracil
- +6 more
-
Aachen, Germany
- +29 more
Nov 1, 2022
Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab)
Recruiting
- Hepatocellular Carcinoma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 4, 2023
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Fluorouracil
- +4 more
-
Houston, Texas
- +3 more
Nov 13, 2022
Gastric Cancer Trial (Penpulimab combination with anlotinib and chemo)
Not yet recruiting
- Gastric Cancer
- Penpulimab combination with anlotinib and chemotherapy
- (no location specified)
May 17, 2022
Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)
Not yet recruiting
- Urothelial Bladder Carcinoma
- Sacituzumab govitecan
- +2 more
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Nov 14, 2023
Immunotherapy, Analgesia, NSCLC Trial in Tianjin (neoadjuvant immunotherapy, Neoadjuvant chemo)
Recruiting
- Immunotherapy
- +3 more
- neoadjuvant immunotherapy
- Neoadjuvant chemotherapy
-
Tianjin, Tianjin, China
- +2 more
Aug 23, 2022
Locally Advanced Rectal Cancer Trial in Shanghai (SHR-1701;Capecitabine;Oxaliplatin)
Recruiting
- Locally Advanced Rectal Cancer
-
Shanghai, Shanghai, ChinaFudan University Zhongshan Hospital
Jul 26, 2022
An Audit of Cytoreductive Surgery and Hyperthermic
Recruiting
- Colorectal Cancer
- +2 more
- Hyperthermic intraperitoneal chemotherapy
-
Mumbai, Maharashtra, IndiaTata Memorial Hospital
Apr 25, 2022
Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)
Active, not recruiting
- Metastatic Colorectal Cancer
- mFOLFOX6
- +3 more
-
Duarte, California
- +6 more
Jan 18, 2023